Huilin Xu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Chemotherapy Induced

Ejection Fraction

Small Cell Lung Cancer

Peritoneal Dialysis

Top Venues

Journal of oncology

Integrative cancer therapies

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Huilin Xu, Dedong Cao, Dingjie Zhou, Anbing He, Wei Ge, Ximing Xu
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Huilin Xu, Dedong Cao, Dingjie Zhou, Anbing He, Wei Ge, Ximing Xu
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Huilin Xu, Pingpo Ming, Zhenyu Zhao, Nan Zhao, Dingjie Zhou, Xixian Tang, Dedong Cao
Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis. Integrative cancer therapies 22 (2023)
Huilin Xu, Dedong Cao, Fangfang Jie, Anbing He, Wei Ge
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis. Tumori (2022)
Huilin Xu, Zhucheng Yin, Anbing He, Dedong Cao
The Impact of Javanica Oil Emulsion Injection on Chemotherapy Efficacy and Cellular Immune Indicators in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)